10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2017 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Revenues: | |||
| Product sales | $ 21,795 | 21,892 | 20,944 |
| Other revenues | 1,054 | 1,099 | 718 |
| Total revenues | 22,849 | 22,991 | 21,662 |
| Operating expenses: | |||
| Cost of sales | 4,069 | 4,162 | 4,227 |
| Research and development | 3,562 | 3,840 | 4,070 |
| Selling, general and administrative | 4,870 | 5,062 | 4,846 |
| Other | 375 | 133 | 49 |
| Total operating expenses | 12,876 | 13,197 | 13,192 |
| Operating income | 9,973 | 9,794 | 8,470 |
| Interest expense, net | 1,304 | 1,260 | 1,095 |
| Interest and other income, net | 928 | 629 | 603 |
| Income before income taxes | 9,597 | 9,163 | 7,978 |
| Provision for income taxes | 7,618 | 1,441 | 1,039 |
| Net income | 1,979 | 7,722 | 6,939 |
| Earnings per share: | |||
| Basic (in usd per share) | 2.71 | 10.32 | 9.15 |
| Diluted (in usd per share) | 2.69 | 10.24 | 9.06 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 731 | 748 | 758 |
| Diluted (in shares) | 735 | 754 | 766 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2017 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Net income | $ 1,979 | 7,722 | 6,939 |
| Other comprehensive (loss) income, net of reclassification adjustments and taxes: | |||
| Foreign currency translation gains (losses) | 81 | (99) | (247) |
| Effective portion of cash flow hedges | (288) | (15) | 7 |
| Net unrealized (losses) gains on available-for-sale securities | (6) | 122 | (241) |
| Other | 5 | 1 | 9 |
| Other comprehensive (loss) income, net of tax | (208) | 9 | (472) |
| Comprehensive income | 1,771 | 7,731 | 6,467 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2017 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash flows from operating activities: | |||
| Net income | $ 1,979 | 7,722 | 6,939 |
| Depreciation and amortization | 1,955 | 2,105 | 2,108 |
| Stock-based compensation expense | 329 | 311 | 322 |
| Deferred income taxes | (1,330) | 183 | (607) |
| Other items, net | 334 | 32 | (146) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (58) | (214) | (420) |
| Inventories | 133 | (80) | 481 |
| Other assets | (24) | (128) | 155 |
| Accounts payable | 424 | (44) | (12) |
| Accrued income taxes, net | 523 | (301) | 509 |
| Long-term tax liability | 6,681 | 445 | 409 |
| Other liabilities | 231 | 323 | (7) |
| Net cash provided by operating activities | 11,177 | 10,354 | 9,731 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (664) | (738) | (594) |
| Cash paid for acquisitions, net of cash acquired | (19) | 0 | (359) |
| Purchases of marketable securities | (33,607) | (28,094) | (25,977) |
| Proceeds from sales of marketable securities | 24,240 | 17,958 | 18,029 |
| Proceeds from maturities of marketable securities | 6,174 | 2,459 | 3,527 |
| Proceeds from sales of property, plant and equipment | 11 | 78 | 274 |
| Other | (159) | (321) | (447) |
| Net cash used in investing activities | (4,024) | (8,658) | (5,547) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,476 | 7,318 | 3,465 |
| Repayment of debt | (4,405) | (3,725) | (2,400) |
| Repurchases of common stock | (3,160) | (2,965) | (1,867) |
| Dividends paid | (3,365) | (2,998) | (2,396) |
| Settlement of contingent consideration obligations | 0 | 0 | (253) |
| Withholding taxes arising from shares withheld for share-based payments | (191) | (260) | (401) |
| Other | 51 | 31 | 81 |
| Net cash used in financing activities | (6,594) | (2,599) | (3,771) |
| Increase (decrease) in cash and cash equivalents | 559 | (903) | 413 |
| Cash and cash equivalents at beginning of year | 3,241 | 4,144 | |
| Cash and cash equivalents at end of year | 3,800 | 3,241 | 4,144 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2017 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,800 | 3,241 |
| Marketable securities | 37,878 | 34,844 |
| Trade receivables, net | 3,237 | 3,165 |
| Inventories | 2,834 | 2,745 |
| Other current assets | 1,727 | 2,015 |
| Total current assets | 49,476 | 46,010 |
| Property, plant and equipment, net | 4,989 | 4,961 |
| Intangible assets, net | 8,609 | 10,279 |
| Goodwill | 14,761 | 14,751 |
| Other assets | 2,119 | 1,625 |
| Total assets | 79,954 | 77,626 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,352 | 917 |
| Accrued liabilities | 6,516 | 5,884 |
| Short-term borrowings and current portion of long-term debt | 1,152 | 4,403 |
| Total current liabilities | 9,020 | 11,204 |
| Long-term debt | 34,190 | 30,193 |
| Long-term deferred tax liabilities | 1,166 | 2,436 |
| Long-term tax liabilities | 9,099 | 2,419 |
| Other noncurrent liabilities | 1,238 | 1,499 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding722.2 shares in 2017 and 738.2 shares in 2016 | 30,992 | 30,784 |
| Accumulated deficit | (5,072) | (438) |
| Accumulated other comprehensive loss | (679) | (471) |
| Total stockholders equity | 25,241 | 29,875 |
| Total liabilities and stockholders equity | 79,954 | 77,626 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |